Effects of Fampridine in People with Multiple Sclerosis: A Systematic Review and Meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Fampridine in People with Multiple Sclerosis: A Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
CNS DRUGS
Volume 33, Issue 11, Pages 1087-1099
Publisher
Springer Science and Business Media LLC
Online
2019-10-14
DOI
10.1007/s40263-019-00671-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years
- (2018) Sarah D. Broicher et al. JOURNAL OF NEUROLOGY
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Dalfampridine benefits ambulation but not cognition in multiple sclerosis
- (2018) Nikhil Satchidanand et al. Multiple Sclerosis Journal
- Multiple Sclerosis and Clinical Gait Analysis before and after Fampridine: A Systematic Review
- (2017) Magaly Lecat et al. EUROPEAN NEUROLOGY
- Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis
- (2017) Linard Filli et al. NEUROLOGY
- The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS
- (2017) Sarah A. Morrow et al. Multiple Sclerosis and Related Disorders
- Macrolide antibiotics and the risk of ventricular arrhythmia in older adults
- (2016) Mai H. Trac et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER
- (2016) Elizabeth W. Triche et al. CLINICAL NEUROPHARMACOLOGY
- Effect of fampridine on axonal excitability in multiple sclerosis
- (2016) William Huynh et al. CLINICAL NEUROPHYSIOLOGY
- Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29
- (2016) Claudio Gasperini et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern
- (2016) Björn Zörner et al. Multiple Sclerosis Journal
- Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern
- (2016) Björn Zörner et al. Multiple Sclerosis Journal
- Dalfampridine effects on cognition, fatigue, and dexterity
- (2016) Melanie Korsen et al. Brain and Behavior
- Effect of slow release-Fampridine on muscle strength, rate of force development, functional capacity and cognitive function in an enriched population of MS patients. A randomized, double blind, placebo controlled study
- (2016) H.B. Jensen et al. Multiple Sclerosis and Related Disorders
- Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial
- (2015) Angela Applebee et al. CLINICAL THERAPEUTICS
- Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis
- (2015) Eloi Magnin et al. EUROPEAN NEUROLOGY
- Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
- (2015) Raymond Hupperts et al. Multiple Sclerosis Journal
- Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
- (2015) Raymond Hupperts et al. Multiple Sclerosis Journal
- What explains functioning from the perspective of people with multiple sclerosis?
- (2014) Andrea Conrad et al. JOURNAL OF NEUROLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients
- (2013) Brendan L Limone et al. Health and Quality of Life Outcomes
- Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy
- (2013) L. Horton et al. NEUROLOGY
- 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review
- (2013) Henrik Boye Jensen et al. Therapeutic Advances in Neurological Disorders
- Dalfampridine in multiple sclerosis: From symptomatic treatment to immunomodulation
- (2011) Carmen Espejo et al. CLINICAL IMMUNOLOGY
- A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
- (2010) Andrew D. Goodman et al. ANNALS OF NEUROLOGY
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
- (2009) Andrew D Goodman et al. LANCET
- Dose comparison trial of sustained-release fampridine in multiple sclerosis
- (2008) A. D. Goodman et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now